Literature DB >> 26094207

An UPLC-MS/MS method for the quantitation of vortioxetine in rat plasma: Application to a pharmacokinetic study.

Er-min Gu1, Chengke Huang2, Bingqing Liang1, Lingjing Yuan1, Tian Lan1, Guoxin Hu3, Hongyu Zhou4.   

Abstract

In this work, a simple, sensitive and fast ultra performance liquid chromatography with tandem mass spectrometry (UPLC-MS/MS) method was developed and validated for the quantitative determination of vortioxetine in rat plasma. Plasma samples were processed with a protein precipitation. The separation was achieved by an Acquity UPLC BEH C18 column (2.1mm×50mm, 1.7μm) column with a gradient mobile phase consisting of 0.1% formic acid in water and acetonitrile. Detection was carried out using positive-ion electrospray tandem mass spectrometry via multiple reaction monitoring (MRM). The validated method had an excellent linearity in the range of 0.05-20ng/mL (R(2)>0.997) with a lower limit of quantification (0.05ng/mL). The extraction recovery was in the range of 78.3-88.4% for vortioxetine and 80.3% for carbamazepine (internal standard, IS). The intra- and inter-day precision was below 8.5% and accuracy was from -11.2% to 9.5%. No notable matrix effect and astaticism was observed for vortioxetine. The method has been successfully applied to a pharmacokinetic study of vortioxetine in rats for the first time, which provides the basis for the further development and application of vortioxetine.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Pharmacokinetics; Plasma; Rat; UPLC–MS/MS; Vortioxetine

Mesh:

Substances:

Year:  2015        PMID: 26094207     DOI: 10.1016/j.jchromb.2015.05.010

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  2 in total

1.  Comparison of Various Chromatographic Systems for Identification of Vortioxetine in Bulk Drug Substance, Human Serum, Saliva, and Urine Samples by HPLC-DAD and LC-QTOF-MS.

Authors:  Anna Petruczynik; Karol Wróblewski; Krzysztof Wojtanowski; Tomasz Mroczek; Dariusz Juchnowicz; Hanna Karakuła-Juchnowicz; Tomasz Tuzimski
Journal:  Molecules       Date:  2020-05-27       Impact factor: 4.411

2.  Development of the Validated Stability-Indicating Method for the Determination of Vortioxetine in Bulk and Pharmaceutical Formulation by HPLC-DAD, Stress Degradation Kinetics Studies and Detection of Degradation Products by LC-ESI-QTOF-MS.

Authors:  Karol Wróblewski; Małgorzata Szultka-Młyńska; Daria Janiszewska; Anna Petruczynik; Bogusław Buszewski
Journal:  Molecules       Date:  2022-03-14       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.